Cargando…
N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
BACKGROUND: Vulvar squamous cell carcinoma (VSCC) is an uncommon gynecologic malignancy but with an increasing incidence in recent years. Etiologically, VSCC is classified into two subtypes: HPV-dependent and HPV-independent. Localized VSCC is treated surgically and/or with radiation therapy, but fo...
Autores principales: | Condic, Mateja, Thiesler, Thore, Staerk, Christian, Klümper, Niklas, Ellinger, Jörg, Egger, Eva K., Kübler, Kirsten, Kristiansen, Glen, Mustea, Alexander, Ralser, Damian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434921/ https://www.ncbi.nlm.nih.gov/pubmed/36050747 http://dx.doi.org/10.1186/s12885-022-10010-x |
Ejemplares similares
-
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
por: Ralser, Damian J., et al.
Publicado: (2022) -
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
por: Condic, Mateja, et al.
Publicado: (2022) -
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target
por: Condic, Mateja, et al.
Publicado: (2023) -
The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023) -
Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology
por: Hecking, Thomas, et al.
Publicado: (2017)